Milind Javle Selected Research

Induction Chemotherapy

11/2022	Nab-Paclitaxel, Capecitabine, and Radiation Therapy After Induction Chemotherapy in Treating Patients With Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase 1 Trial and Imaging-based Biomarker Validation.
12/2016	Preoperative Chemoradiation for Pancreatic Adenocarcinoma Does Not Increase 90-Day Postoperative Morbidity or Mortality.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Milind Javle Research Topics

Disease

92	Neoplasms (Cancer) 05/2024 - 11/2004
36	Cholangiocarcinoma 03/2024 - 07/2007
32	Adenocarcinoma 11/2022 - 05/2004
29	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 02/2009
11	Gallbladder Neoplasms (Gallbladder Cancer) 12/2023 - 01/2013
10	Biliary Tract Neoplasms (Biliary Tract Cancer) 12/2023 - 05/2015
8	Neoplasm Metastasis (Metastasis) 08/2023 - 03/2010
7	Colorectal Neoplasms (Colorectal Cancer) 07/2018 - 11/2004
6	Hepatocellular Carcinoma (Hepatoma) 04/2022 - 01/2005
6	Carcinoma (Carcinomatosis) 06/2021 - 04/2009
5	Esophageal Neoplasms (Esophageal Cancer) 02/2009 - 07/2005
4	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 11/2009
4	Melanoma (Melanoma, Malignant) 02/2024 - 12/2017
4	Disease Progression 10/2021 - 01/2018
4	Stomach Neoplasms (Stomach Cancer) 05/2015 - 02/2009
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 03/2010
3	Klatskin Tumor 01/2018 - 05/2011
3	Hemorrhage 10/2013 - 11/2009
2	Microsatellite Instability 03/2024 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 05/2011
2	Residual Neoplasm 02/2023 - 01/2022
2	Nausea 01/2021 - 02/2017
2	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2018
2	Neutropenia 01/2018 - 11/2010
2	Carcinogenesis 02/2016 - 05/2004
2	Hypertension (High Blood Pressure) 12/2014 - 09/2007
2	Drug-Related Side Effects and Adverse Reactions 11/2010 - 01/2010
2	Rectal Neoplasms (Rectal Cancer) 03/2010 - 12/2005
1	Inflammation (Inflammations) 03/2024

Drug/Important Bio-Agent (IBA)

23	Gemcitabine FDA Link 01/2022 - 08/2005
11	Biomarkers (Surrogate Marker)IBA 03/2024 - 11/2010
10	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2021 - 11/2004
9	Capecitabine (Xeloda)FDA Link 11/2022 - 08/2005
9	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 08/2005
6	Cell-Free Nucleic AcidsIBA 11/2023 - 09/2017
6	Fluorouracil (Carac)FDA LinkGeneric 12/2020 - 08/2007
6	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2004
5	Trastuzumab (Herceptin)FDA Link 01/2021 - 03/2010
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 12/2016 - 01/2014
4	RNA (Ribonucleic Acid)IBA 05/2024 - 06/2014
4	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 11/2023 - 01/2021
4	Paclitaxel (Taxol)FDA LinkGeneric 02/2023 - 02/2009
4	Bevacizumab (Avastin)FDA Link 04/2022 - 09/2007
4	infigratinibIBA 10/2021 - 01/2018
4	LigandsIBA 12/2020 - 01/2014
4	AntigensIBA 10/2020 - 11/2017
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 08/2007
3	human ERBB2 proteinIBA 05/2024 - 03/2010
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2024 - 12/2016
3	Circulating Tumor DNAIBA 02/2023 - 01/2020
3	Carboplatin (JM8)FDA LinkGeneric 02/2023 - 11/2004
3	VemurafenibIBA 02/2023 - 01/2019
3	Sorafenib (BAY 43-9006)FDA Link 02/2023 - 02/2009
3	130-nm albumin-bound paclitaxelIBA 11/2022 - 02/2019
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2022 - 01/2019
3	Leucovorin (Folinic Acid)FDA Link 01/2021 - 08/2007
3	ParaffinIBA 01/2020 - 12/2005
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018 - 10/2013
3	Monoclonal AntibodiesIBA 01/2018 - 12/2014
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2018 - 05/2011
2	InterferonsIBA 05/2024 - 12/2011
2	futibatinibIBA 11/2023 - 01/2022
2	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2022
2	Mitogen-Activated Protein KinasesIBA 02/2022 - 01/2020
2	RamucirumabIBA 01/2022 - 12/2014
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 12/2020
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2021 - 04/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2021 - 04/2011
2	PlatinumIBA 05/2021 - 09/2015
2	pertuzumabIBA 01/2021 - 05/2015
2	trametinibIBA 01/2020 - 01/2020
2	folfirinoxIBA 01/2020 - 01/2019
2	Calcitriol (Calcijex)FDA LinkGeneric 10/2018 - 11/2005
2	dalotuzumabIBA 01/2018 - 12/2014
2	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2016 - 12/2016
2	ChromatinIBA 11/2016 - 01/2014
2	MetalsIBA 12/2011 - 05/2011
2	Docetaxel (Taxotere)FDA Link 01/2010 - 08/2005
2	Trefoil Factor-3IBA 07/2007 - 01/2005
1	GenieIBA 05/2024
1	zanidatamabIBA 02/2024
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 02/2024
1	Interleukin-2 (IL2)IBA 02/2024
1	urelumabIBA 02/2024

Therapy/Procedure

60	Therapeutics 02/2024 - 07/2005
33	Drug Therapy (Chemotherapy) 02/2024 - 12/2005
13	Radiotherapy 09/2023 - 09/2006
6	Immunotherapy 02/2024 - 07/2018
6	Neoadjuvant Therapy 01/2023 - 07/2007
6	Pancreatectomy 01/2022 - 03/2007
5	Liver Transplantation 01/2022 - 01/2018
5	Chemoradiotherapy 08/2015 - 01/2010
4	Contraindications 01/2022 - 01/2018
4	Stents 01/2018 - 09/2006
4	Pancreaticoduodenectomy 01/2017 - 12/2011
2	Aftercare (After-Treatment) 11/2023 - 08/2008
2	Induction Chemotherapy 11/2022 - 12/2016
2	Precision Medicine 01/2021 - 06/2020
2	Palliative Care (Palliative Therapy) 08/2015 - 05/2011